Allapininum

高乌甲素

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAllapininum
Drug Alias NameLappaconitine氢溴酸高乌甲素Allapinine (HBr salt)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsPainArrhythmias, CardiacHyperemesis Gravidarum
Global Approved IndicationsHyperemesis Gravidarum
Approved Indications in ChinaHyperemesis Gravidarum
Original Approved Country/TerritoryMainland China
Original Approved Date1987/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesHarbin Pharm Group Sanjing Pharmaceutical Co LtdHarbin Pharmaceutical Group Sanjing Pharmaceutical No. 4 Factory Co Ltd
Inactive CompaniesAll-Union Cardiology Research CentreShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Active IndicationsPainHyperemesis Gravidarum
Inactive IndicationsArrhythmias, Cardiac

Other Information

ATC CodeN02
Related LinksN/A